SOBRsafe Inc. (NASDAQ: SOBR), a leader in advanced alcohol monitoring and detection technology, has announced a 92.3% year-over-year revenue growth for the second quarter of 2025, achieving $104,200 in revenue. This impressive growth is largely due to the strong sales performance of its SOBRsure(TM) GEN 2 hardware and software, which made up 76.5% of the total revenue. The company also reported a notable improvement in gross margin, which rose by 380 basis points to 57.5%, alongside a reduction in net loss to $2.0 million from $2.1 million in the same quarter the previous year.
Operational milestones for SOBRsafe in Q2 2025 included the shipment of 178 SOBRsure(TM) GEN 2 devices, marking a 35.9% increase from the first quarter. The company also experienced a 109.6% year-over-year growth in annual recurring software subscription revenue, now accounting for 55.2% of the quarterly revenue. Key achievements during the quarter were the independent third-party validation of the SOBRsure(TM) GEN 2 performance, the introduction of an upgraded B2B e-commerce platform, and the granting of a European Patent for SOBRcheck(TM). Additionally, SOBRsafe expanded its sales force and ventured into the Family Law market, demonstrating its dedication to expanding its market presence.
Financially, SOBRsafe ended the quarter with $8.5 million in cash and equivalents, highlighting the company's robust financial health and its ability to support ongoing growth strategies. SOBRsafe's pioneering transdermal technology, which offers a non-invasive method for alcohol detection, sets it apart in the behavioral health, family law, and consumer sectors. For further details on SOBRsafe's innovative solutions and financial achievements, visit https://www.sobrsafe.com.
